Premium
Antimicrobial therapy in neonatal foals
Author(s) -
Corley K. T. T.,
Hollis A. R.
Publication year - 2009
Publication title -
equine veterinary education
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.304
H-Index - 31
eISSN - 2042-3292
pISSN - 0957-7734
DOI - 10.2746/095777309x445352
Subject(s) - foal , medicine , antimicrobial , enrofloxacin , enteral administration , horse , antibiotics , intensive care medicine , microbiology and biotechnology , ciprofloxacin , biology , parenteral nutrition , paleontology , genetics
Summary There are several differences in treatment of neonatal foals with antimicrobials, compared to mature horses. Firstly, the dose of many antimicrobials is different in the foal. For orally administered drugs, this may also affect their efficacy, due to different enteral absorption. Secondly, neonatal foals are not yet hindgut fermentors and this allows antimicrobials with a high propensity to cause colitis in mature horses to be used. Thirdly, toxicities are different and some antimicrobials used in mature horses, such as enrofloxacin, are not suitable for use in foals. Foal‐specific information is therefore needed for their safe and effective treatment with antimicrobials.